Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Now watching

Next video starts in : 7 Play

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted
Replay video
Up next

American Express Misses on Revenue, Hurt By Stronger Dollar

Unlock your personal NFL Now stream by signing in to NFL.com

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Analysts at Jefferies are estimating that pharmaceutical company AbbVie could find itself a deal if it sweetens its $46 billion takeover offer for London-listed rival Shire. Jefferies analysts estimate that AbbVie could improve its offer to 55 pounds a share, or $55 billion. That's up from its most recent cash-and-shares offer of just over 46 pounds, which was rejected. Shire has argued that AbbVie's offer undervalues its business. Since the offer, Shire is giving long-range forecasts for its drugs, predicting that its $4.9 billion in sales in 2013 may double to $10 billion by 2020, helped by its successful ADHD treatment.

TheStreet

Finance

  1. 4:19

    R.I.P. bull market?

  2. 14:02

    Bull market bust, GE reports and the secret to a successful fundraising campaign

  3. 3:15

    GE stock clinging to gains after earnings report

  4. 2:12

    Apple Watch, Greece, earnings from Facebook and Google: What to watch next week

  5. 2:05

    The sexy secret to a successful fundraising campaign

  6. 13:18

    Investors eye inflation; GE's earnings; Mattel's crowdsourcing